Topics:
Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Moffitt Cancer Center • HR+ • NCI-CCC Breast Tumor Board Question
How do you manage adjuvant endocrine therapy for pre-menopausal women with locally advanced, weakly positive ER/PR, HER2 negative breast cancer?
Would a pCR to neoadjuvant chemotherapy change your management? (ER <5%, PR <5%)
Answer from: Medical Oncologist at Community Practice
Likely very little benefit. Reasonable to try tamoxifen if tolerated.
Sign in or Register to read more